Lynda Smith Harris
Addiction Medicine · Brooklyn, NYNPI 1831272947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 332 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,786 and has fallen 58.5% since, to $742 in 2025. Among addiction medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 332 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$862
- Lundbeck LLC$545
- Otsuka America Pharmaceutical, Inc.$517
- plus $1K from 11 others
What the payments were for
- Food & beverage$6,28594%
- Education$4276%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 58 | $1,400 |
| AbbVie(2 entities) | 82 | $1,238 |
| Neurocrine Biosciences, Inc. | 56 | $1,092 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $862 |
| Lundbeck LLC | 23 | $545 |
| Otsuka America Pharmaceutical, Inc. | 22 | $517 |
| Alkermes, Inc. | 12 | $259 |
| Johnson & Johnson | 10 | $202 |
| E.r. Squibb & Sons, L.L.C. | 6 | $143 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| Indivior Inc. | 5 | $110 |
| Noven Therapeutics, LLC | 6 | $107 |
| Pfizer | 1 | $34 |
| Merck | 1 | $24 |
| GSK | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $15 |
How this compares
$6,712 in reported general payments places this provider in the 90th percentile of 125 addiction medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 15 | $38,668 |
| DayvigoLemborexant | 11 | $3,720 |
| Quetiapine Fumarate | 241 | $2,137 |
| Bupropion XlBupropion Hcl | 89 | $1,292 |
| Aripiprazole | 60 | $996 |
| Alprazolam | 100 | $907 |
| Clonazepam | 135 | $698 |
| Sertraline Hcl | 123 | $612 |
| Gabapentin | 82 | $604 |
| Amitriptyline Hcl | 43 | $554 |
| Buspirone Hcl | 43 | $519 |
| Zolpidem Tartrate | 99 | $503 |
| Risperidone | 62 | $495 |
| Carbamazepine ErCarbamazepine | 13 | $473 |
| Lorazepam | 22 | $469 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $517 | $38,66815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 125 addiction medicine providers in New York.
Other addiction medicine in Brooklyn
- Alejo ParelladaBrooklyn$22K
- Oskar VarshavskiyBrooklyn$7K
- Jacquelin BelamyBrooklyn$778
- Edmond HakimiCalverton$125K
- Alain LitwinBronx$124K
- John MarianiNew York$38K
- Stefan KantrowitzNew York$33K
- Sean ChappinAlbany$20K
- Mohammad KabirTroy$15K
- Sonia LopezJamaica$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.